Human IL-33 DuoSet ELISA, 15 Plate

Images

 

Product Details

Summary
Reactivity HuSpecies Glossary
Applications ELISA
Conjugate
Biotin

Order Details

Human IL-33 DuoSet ELISA, 15 Plate Summary

Source
N/A
Assay Type
Solid Phase Sandwich ELISA
Inter-Assay
See PDF Datasheet for details
Intra-Assay
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details

Applications/Dilutions

Dilutions
  • ELISA
Application Notes
No significant interference observed with available related molecules.
Reviewed Applications
Read 1 Review rated 4
using
DY3625B in the following application:

Publications
Read Publications using DY3625B.

Packaging, Storage & Formulations

Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human IL-33 DuoSet ELISA, 15 Plate

  • C9orf26
  • C9orf26chromosome 9 open reading frame 26 (NF-HEV)
  • DKFZp586H0523
  • DVS27
  • DVS27-related protein
  • IL1F11
  • IL-1F11
  • IL33
  • IL-33
  • interleukin 33
  • Interleukin-1 family member 11
  • interleukin-33
  • NFHEV
  • NF-HEV
  • NF-HEVNFEHEV
  • Nuclear factor from high endothelial venules
  • RP11-575C20.2

Background

IL-33 (Interleukin-33) is released from physically damaged or necrotic cells. It triggers Th2-biased immune cell activation at sites of inflammation as well as regulatory T cell and M2 macrophage expansion. It additionally induces angiogenesis, promotes tumor cell migration and invasion, limits cardiac myocyte hypertrophy, and limits the development of atherosclerotic plaques. IL-33 signals through a receptor complex composed of ST2 and IL-1 RAcP. IL-1 RAcP also associates with IL-1 RI, IL-1 RII, IL-1 R6, and SCF R/c-kit. Soluble isoforms of ST2 and IL-1 RAcP function as decoy receptors that regulate IL-33 bioactivity.

Customers Who Viewed This Item Also Viewed...

DY523B-05
Species: Hu
Applications: ELISA
AF5828
Species: Hu
Applications: ICC, Neut, WB
DY413
Species: Mu
Applications: ELISA
7625
Species: Mu
Applications: ELISA
6507-IL/CF
Species: Hu
Applications: BA
201-LB
Species: Hu
Applications: BA
M5000
Species: Mu
Applications: ELISA
M6000B
Species: Mu
Applications: ELISA
NBP1-81595
Species: Hu
Applications: IHC, IHC-P, WB
1398-TS/CF
Species: Hu
Applications: BA
AF676
Species: Hu
Applications: CyTOF-ready, Flow, WB
DY421
Species: Mu
Applications: ELISA
NB100-56565
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
MAB208
Species: Hu
Applications: CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, ICFlow, Neut, Simple Western, WB
DCP00
Species: Hu
Applications: ELISA
NB100-56583
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, WB
DY3625B
Species: Hu
Applications: ELISA

Publications for IL-33 (DY3625B)(36)

We have publications tested in 3 confirmed species: Human, Mouse, Transgenic Mouse.


Filter By Application
All Applications
Filter By Species
Human
(34)
Mouse
(2)
Transgenic Mouse
(1)
All Species
Showing Publications 1 - 10 of 36. Show All 36 Publications.
Publications using DY3625B Applications Species
Jiao, M;Wang, C;Tang, X;Dai, C;Zhang, N;Fan, A;Qian, Z;Liu, S;Zhang, F;Li, B;Xu, Y;Tan, Z;Gong, F;Lu, Y;Zheng, F; Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis Brain, behavior, and immunity 2024-04-24 [PMID: 38663774] (Mouse, Transgenic Mouse) Mouse, Transgenic Mouse
Raphael, HE;Hassan, GF;Osorio, OA;Cohen, LS;Payne, MD;Katz-Kiriakos, E;Tata, I;Hicks, J;Byers, DE;Zhang, B;Alexander-Brett, J; Activator protein transcription factors coordinate human IL-33 expression from noncanonical promoters in chronic airway disease JCI insight 2024-03-08 [PMID: 38456508] (Human) Human
Coufal, S;Kverka, M;Kreisinger, J;Thon, T;Rob, F;Kolar, M;Reiss, Z;Schierova, D;Kostovcikova, K;Roubalova, R;Bajer, L;Jackova, Z;Mihula, M;Drastich, P;Tresnak Hercogova, J;Novakova, M;Vasatko, M;Lukas, M;Tlaskalova-Hogenova, H;Jiraskova Zakostelska, Z; Serum TGF-?1 and CD14 Predicts Response to Anti-TNF-? Therapy in IBD Journal of immunology research 2023-06-20 [PMID: 37383609] (Human) Human
England, E;Rees, DG;Scott, IC;Carmen, S;Chan, DTY;Chaillan Huntington, CE;Houslay, KF;Erngren, T;Penney, M;Majithiya, JB;Rapley, L;Sims, DA;Hollins, C;Hinchy, EC;Strain, MD;Kemp, BP;Corkill, DJ;May, RD;Vousden, KA;Butler, RJ;Mustelin, T;Vaughan, TJ;Lowe, DC;Colley, C;Cohen, ES; Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction Scientific reports 2023-06-17 [PMID: 37330528] (Human) Human
Jeon, YJ;Gil, CH;Won, J;Jo, A;Kim, HJ; Symbiotic microbiome Staphylococcus epidermidis restricts IL-33 production in allergic nasal epithelium via limiting the cellular necroptosis BMC microbiology 2023-05-26 [PMID: 37237381] (Mouse) Mouse
J Nesic, B Ljujic, V Rosic, A Djukic, M Rosic, I Petrovic, N Zornic, IP Jovanovic, S Petrovic, S Djukic Adiponectin and Interleukin-33: Possible Early Markers of Metabolic Syndrome Journal of Clinical Medicine, 2022-12-24;12(1):. 2022-12-24 [PMID: 36614933] (Human) Human
MH Urban, S Stojkovic, S Demyanets, C Hengstenbe, A Valipour, J Wojta, OC Burghuber Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease-A 10-Year Cohort Study Journal of Clinical Medicine, 2021-12-23;11(1):. 2021-12-23 [PMID: 35011794] (Human) Human
W Fonseca, N Asai, K Yagi, CA Malinczak, G Savickas, CC Johnson, S Murray, EM Zoratti, NW Lukacs, J Li, CF Schuler Iv COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males Viruses, 2021-12-02;13(12):. 2021-12-02 [PMID: 34960684] (Human) Human
ICS Dias, SM de Campos-, ELM Vieira, APL Mota, PS Azevedo, VTDS Anício, FC Guimarães, LM Mantovani, BF Cruz, AL Teixeira, JV Salgado Adiponectin and Stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia Journal of psychiatric research, 2021-11-09;0(0):. 2021-11-09 [PMID: 34785039] (Human) Human
R Rezar, V Paar, C Seelmaier, I Pretsch, P Schwaiger, K Kopp, R Kaufmann, TK Felder, E Prinz, G Gemes, R Pistulli, UC Hoppe, B Wernly, M Lichtenaue Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study Scientific Reports, 2021-11-05;11(1):21756. 2021-11-05 [PMID: 34741120] (Human) Human
Show All 36 Publications.

Review for IL-33 (DY3625B) (1) 41

Average Rating: 4
(Based on 1 review)

Reviews using DY3625B:
Filter by Applications
All Applications
Filter by Species
All Species
Images Ratings Applications Species Date Details
  4
reviewed by:
Patricia Carulla Martí
06/28/2023
View

Summary

Sample TestedCultured Human Keratinocytes,Supernatant from cultured human epidermal keratinocytes (HEKa)
LotP163207

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for IL-33 (DY3625B) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional IL-33 Products

Blogs on IL-33.

Interleukin 33 (IL-33) - A dual function cytokine
IL-33 is a member of the interleukin family of cytokines that regulates a wide variety of cellular functions. Its receptor is ST2, an IL-1 receptor family member that also acts as a negative regulator of TLR-IL-1R signaling and the IL-1R accessory ...  Read full blog post.

Read our latest blog and use the new citation tool on bio-techne.com

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Recent Reviews

4
5
0
4
1
3
0
2
0
1
0

Patricia Carulla Martí
06/28/2023
Application:
Species: